Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1978 1
1980 1
1984 1
1985 4
1987 2
1988 2
1990 1
1991 4
1993 1
1994 1
1997 1
2005 1
2007 1
2010 1
2012 1
2015 4
2016 3
2017 3
2018 4
2019 1
2020 5
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Results by year
Filters applied: . Clear all
Page 1
Role of targeted therapy in metastatic colorectal cancer.
Ohhara Y, Fukuda N, Takeuchi S, Honma R, Shimizu Y, Kinoshita I, Dosaka-Akita H. Ohhara Y, et al. World J Gastrointest Oncol. 2016 Sep 15;8(9):642-55. doi: 10.4251/wjgo.v8.i9.642. World J Gastrointest Oncol. 2016. PMID: 27672422 Free PMC article. Review.
The presence of odd-chain fatty acids in Drosophila phospholipids.
Sato A, Ohhara Y, Miura S, Yamakawa-Kobayashi K. Sato A, et al. Among authors: ohhara y. Biosci Biotechnol Biochem. 2020 Oct;84(10):2139-2148. doi: 10.1080/09168451.2020.1790337. Epub 2020 Jul 7. Biosci Biotechnol Biochem. 2020. PMID: 32633700
Expression of the immunoproteasome subunit β5i in non-small cell lung carcinomas.
Kiuchi T, Tomaru U, Ishizu A, Imagawa M, Iwasaki S, Suzuki A, Otsuka N, Ohhara Y, Kinoshita I, Matsuno Y, Dosaka-Akita H, Kasahara M. Kiuchi T, et al. Among authors: ohhara y. J Clin Pathol. 2021 May;74(5):300-306. doi: 10.1136/jclinpath-2020-206618. Epub 2020 Sep 17. J Clin Pathol. 2021. PMID: 32943490
Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.
Kikuchi J, Ohhara Y, Takada K, Tanabe H, Hatanaka K, Amano T, C Hatanaka K, Hatanaka Y, Mitamura T, Kato M, Shibata Y, Yabe I, Endoh A, Komatsu Y, Matsuno Y, Sugiyama M, Manabe A, Sakurai A, Takahashi M, Naruse H, Torimoto Y, Dosaka-Akita H, Kinoshita I. Kikuchi J, et al. Among authors: ohhara y. Jpn J Clin Oncol. 2021 Apr 30;51(5):753-761. doi: 10.1093/jjco/hyaa277. Jpn J Clin Oncol. 2021. PMID: 33532831
Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Taguchi J, Shimizu Y, Ariga S, Goda T, Ohhara Y, Honma R, Noguchi T, Takeuchi S, Kinoshita I, Amano T, Mizumachi T, Kano S, Takahara M, Abe T, Homma A, Dosaka-Akita H. Taguchi J, et al. Among authors: ohhara y. Int J Clin Oncol. 2021 Jan;26(1):51-58. doi: 10.1007/s10147-020-01788-6. Epub 2020 Sep 29. Int J Clin Oncol. 2021. PMID: 32996023 Clinical Trial.
49 results